ORLANDO, FL / ACCESS Newswire / February 27, 2026 / RedChip Companies will air interviews with 60 Degrees Pharmaceuticals, ...
Doctors at Johns Hopkins Hospital took Henrietta Lacks’ cervical cells in 1951 without her knowledge. Those HeLa cells became ...
Ironwood Pharmaceuticals is downgraded from a 'Buy' to a 'Sell' due to pipeline setbacks and declining LINZESS sales. Click ...
Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) is one of the top gene therapy stocks to buy according to hedge funds.
2d
Forget Centessa Pharmaceuticals: This Rare‑Disease Specialist Has a Superior Portfolio and Pipeline
Centessa Pharmaceuticals is developing a medicine called ORX750 for narcolepsy type 1 (NT1), narcolepsy type 2 (NT2), and ...
FORT PIERCE — A local pharmaceutical company, Mohnark Pharmaceuticals, plans to expand its operation, hiring 11 employees and investing about $2 million in property and equipment, according to city ...
GoodRx projects Pharma Direct revenue to grow at least 30% year-over-year in 2026. Management anticipates continued acceleration in condition-specific subscriptions launched in late 2025, with weight ...
In the assessment of 12-month price targets, analysts unveil insights for Collegium Pharmaceutical, presenting an average ...
New Members of the Strengthened Leadership Team Add Decades of Operational Execution, Pipeline Optimization and Transactional ...
Find latest healthcare news from every corner of the globe at Reuters.com, your online source for breaking international news ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results